BioPharma Credit (BPCR) Share Price, News & Analysis

Company Overview

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.

Key Stats

• Today's Range: 0.90 to 0.91
• 50-Day Range: 0.86 to 0.90
• 52-Week Range: 0.80 to 0.98
• Volume: 1.53 million shs
• Average Volume: 867,439 shs
• Market Capitalization: £1.07 billion
• P/E Ratio: 10.25
• Dividend Yield: 776.05%
• Price Target: N/A
• Consensus Rating: N/A

BPCR Stock Analysis - Frequently Asked Questions

How have BPCR shares performed this year?

BioPharma Credit's stock was trading at GBX 0.88 at the beginning of 2025. Since then, BPCR stock has increased by 2.0% and is now trading at GBX 0.90.

How do I buy shares of BioPharma Credit?

Shares of BPCR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of BioPharma Credit own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BioPharma Credit investors own include AFPO.L (AFPO), Altius Minerals (ATUSF), LiDCO Group Plc (LID.L) (LID), NexGen Energy (NXE), Peninsula Energy (PEN), Premier African Minerals (PREM) and 21512 (SAT.L) (SAT).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: N/A
• Current Symbol: LON:BPCR
• CIK: N/A
• Web: www.bpcruk.com
• Phone: 44 13 9247 7500
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): GBX 0.09
• Trailing P/E Ratio: 10.33
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £10.42 billion
• Net Margins: 80.20%
• Pretax Margin: N/A
• Return on Equity: 8.51%
• Return on Assets: 4.98%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 21.50
• Quick Ratio: 14.07

Sales & Book Value

• Annual Sales: £12.99 billion
• Price / Sales: 0.08
• Cash Flow: GBX 0.76 per share
• Price / Cash Flow: 1.19
• Book Value: GBX 98.56 per share
• Price / Book: 0.01

Miscellaneous

• Outstanding Shares: 118,721,336,824
• Free Float: N/A
• Market Cap: £1.08 billion
• Optionable: Not Optionable
• Beta: 0.22